Eremomycin pyrrolidide: a novel semisynthetic glycopeptide with improved chemotherapeutic properties. (Record no. 28857460)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01903 a2200529 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250518000522.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201902s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1177-8881 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.2147/DDDT.S173923 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Olsufyeva, Evgenia N |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20190205 |
| 245 00 - TITLE STATEMENT | |
| Title | Eremomycin pyrrolidide: a novel semisynthetic glycopeptide with improved chemotherapeutic properties. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Drug design, development and therapy |
| Date of publication, distribution, etc. | 2018 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 2875-2885 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Animals |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Anti-Bacterial Agents |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Dose-Response Relationship, Drug |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Resistance, Bacterial |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Enterococcus faecium |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Glycopeptides |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Mice |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Mice, Hairless |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Mice, Inbred CBA |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Microbial Sensitivity Tests |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Molecular Conformation |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Pyrrolidines |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Shock, Septic |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Staphylococcal Infections |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Staphylococcus aureus |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Structure-Activity Relationship |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Vancomycin Resistance |
| General subdivision | drug effects |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Shchekotikhin, Andrey E |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bychkova, Elena N |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Pereverzeva, Eleonora R |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Treshalin, Ivan D |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mirchink, Elena P |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Isakova, Elena B |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Chernobrovkin, Mikhail G |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kozlov, Roman S |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Dekhnich, Andrey V |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Preobrazhenskaya, Maria N |
| 773 0# - HOST ITEM ENTRY | |
| Title | Drug design, development and therapy |
| Related parts | vol. 12 |
| -- | p. 2875-2885 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.2147/DDDT.S173923">https://doi.org/10.2147/DDDT.S173923</a> |
| Public note | Available from publisher's website |
No items available.